US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

25.77

+0.17820.70%

Post-market: 25.59-0.1782-0.69%16:10 EDT

Volume:307

Turnover:8K

Market Cap:5.15M

PE:- -

High:25.77

Open:25.59

Low:25.77

Close:25.59

52wk High:27.94

52wk Low:22.63

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.37

T/O Rate:0.15%

Dividend:0.41

Dividend Rate:1.60%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scholar Rock Exec Says Its First Drug to Target Muscle Loss in Spinal MusCuLar atRoPhy Has a Wholesale Acquisition Cost of $11,659 for a Single Use Vial - Conf.call

THOMSON REUTERS

Scholar Rock Exec Says Co Expects the Annual Net Cost in the U.S. for a Typical Patient to be Approximately $310,000

THOMSON REUTERS

Scholar Rock price target raised to $84 from $76 at BMO Capital

Top Premarket Gainers

MT Newswires Live

Truist Raises Price Target on Scholar Rock Holding to $76 From $55, Keeps Buy Rating

MT Newswires Live

Scholar Rock Shares up 11.6% Premarket After FDA Nod for First Muscle-Targeted Drug for Type of Genetic Disease

THOMSON REUTERS

Scholar Rock Holding Corporation : Citigroup Raises Target Price to $74 from $60

THOMSON REUTERS

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Scholar Rock Gets FDA Approval for Spinal Muscular Atrophy Treatment in Children, Adults; Shares Up Pre-Bell

MT Newswires Live

Novo Nordisk to Rebrand as Novo

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Scholar Rock Holding (SRRK) and Danaher (DHR)

Novo Nordisk Stock Slides as GLP-1 Fears Mount

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

Scholar Rock announces FDA approval of isembyld

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy Patients Aged 2 and Older on SMN2 Therapy

Scholar Rock Holding Corporation - Isembyld U.S. Commercial Launch Underway; Product Available to Ship in Coming Days

THOMSON REUTERS

Scholar Rock Announces FDA Approval of Isembyld™ (Apitegromab-Mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (Sma)

THOMSON REUTERS

US FDA Approves Scholar Rock's Muscle Weakness Drug

US FDA - Approves Isembyld for Spinal Muscular Atrophy in Patients Aged 2 Years and Older

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/THNR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"THNR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","market":"US","secType":"STK","nameCN":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","latestPrice":25.7682,"timestamp":1789416000000,"preClose":25.59,"halted":0,"volume":307,"hourTrading":{"tag":"盘后","latestPrice":25.59,"preClose":25.7682,"latestTime":"16:10 EDT","volume":6,"amount":154.5128,"timestamp":1789416604141,"change":-0.1782,"changeRate":-0.006916,"amplitude":0},"delay":0,"changeRate":0.0069636576787807875,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Not Yet Opened","change":0.1782,"latestTime":"09-14 16:00:00 EDT","open":25.59,"high":25.7682,"low":25.7682,"amount":7935,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":25.59,"sharesOutstanding":170000,"nav":25.52,"aum":5104000,"dividendRate":0.015989,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":26.05,"preClose":25.59,"latestTime":"09:05 EDT","volume":4,"amount":104.2,"timestamp":1789391120799,"change":0.46,"changeRate":0.017976,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":25.59,"preClose":25.7682,"latestTime":"16:10 EDT","volume":6,"amount":154.5128,"timestamp":1789416604141,"change":-0.1782,"changeRate":-0.006916,"amplitude":0},"volumeRatio":0.371401},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THNR\",,,,,undefined,":{"symbol":"THNR","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.371401,"shares":200000,"dividePrice":0.412,"high":25.7682,"amplitude":0,"preClose":25.59,"low":25.7682,"week52Low":22.6289,"pbRate":"--","week52High":27.94,"institutionHeld":0,"latestPrice":25.7682,"eps":0,"divideRate":0.015989,"volume":307,"delay":0,"ttmEps":0,"open":25.59,"prevYearClose":25.22,"prevWeekClose":25.59,"prevMonthClose":26.6886,"prevQuarterClose":25.6909,"fiveDayClose":27.0064,"twentyDayClose":26.1601,"sixtyDayClose":24.2626},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THNR\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"THNR","amount":0.41317273,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2025-12-31"},{"date":"2024-12-30","symbol":"THNR","amount":0.219898,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THNR\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2024-12-31","value":0.219898,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2025-12-31","value":0.41317273,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THNR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THNR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667665714","title":"Scholar Rock Exec Says Its First Drug to Target Muscle Loss in Spinal MusCuLar atRoPhy Has a Wholesale Acquisition Cost of $11,659 for a Single Use Vial - Conf.call","url":"https://stock-news.laohu8.com/highlight/detail?id=2667665714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667665714?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:27","pubTimestamp":1789388820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN45604N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","IBRN","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667166571","title":"Scholar Rock Exec Says Co Expects the Annual Net Cost in the U.S. for a Typical Patient to be Approximately $310,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2667166571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667166571?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:27","pubTimestamp":1789388820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN45604N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","THNR","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","SYNB","BK4139","MRNY","SRRK","IEIH","FRTY","BK4588","BK4585","MRNX","IBRN","LFSC","IBB","GDOC","BBP","BMED","PSCH","GNMX","TECB","XLVX","THNR","NVIB","RSPH","IDNA","IYH","LABU","PINK","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667482668","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667482668","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667482668?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:23","pubTimestamp":1789385017,"startTime":"0","endTime":"0","summary":"Elmet  shares were up more than 46% in Monday's premarket activity after the company said it will receive $450 million in committed investment from the US Department of Defense to expand domestic manufacturing and bolster the supply chain for the strategically important tungsten.Rum Group  stock was up 13% after The Information reported over the weekend that Amazon-backed  Anthropic has entered into a $13.70 billion, six-year computing deal with Rum Group, which hosts US President Donald Trump's Truth Social platform.CEA Industries  shares were up more than 13% after a 3.8% fall in the prior session.Scholar Rock  stock was 9% higher after the company said Friday it received US Food and Drug Administration approval for Isembyld to treat spinal muscular atrophy in certain patients aged two years and above.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXQ63.HKD","SG9999014914.USD","LU2462157665.USD","IE0000B7K699.USD","LU1989764748.USD","LU2756315318.SGD","LU2381873111.SGD","LU1823568750.SGD","LU1551013342.USD","LU1153585028.USD","LU2065170008.USD","LU1883839398.USD","LU1880398471.USD","LU0070302665.USD","LU1979441026.SGD","LU0345774631.USD","LU2023250504.SGD","LU0642271901.SGD","LU1935043023.USD","LU2125154935.USD","LU0823411888.USD","LU1066051811.HKD","LU1880398554.USD","LU0390134368.USD","BK4604","AMZO","LU0198837287.USD","LU0061474705.USD","LU0957791311.USD","LU0689472784.USD","LU0082616367.USD","LU1934455277.USD","BK4612","LU2505996681.GBP","LU2065171402.SGD","SG9999001077.SGD","IE00BKVL7J92.USD","LU2487616109.SGD","LU0138981039.USD","SG9999015945.SGD","LU0786609619.USD","LU0048573561.USD","LU1066051498.USD","LU2089283258.USD","LU0097036916.USD","LU2063271972.USD","AMAA","IE0004091025.USD","AMZN","LU2420271590.USD","SGXZ23171101.USD","BK4086","BK4220","LU1868836757.USD","IE00B19Z3B42.SGD","LU0648001328.SGD","LU0056508442.USD","IE000MB6IJN5.SGD","LU1429558221.USD","LU2213496289.HKD","LU0175139822.USD","LU2360106780.USD","LU1691799644.USD","IE000YTNTUN2.SGD","LU1037948897.HKD","LU2271345857.HKD","LU0871640123.AUD","LU1244550494.USD","BK4581","IE00BMPRXR70.SGD","LU0174119429.USD","LU0215105999.USD","LU1852331112.SGD","LU2242650005.HKD","LU0210528500.USD","LU0130102774.USD","LU2471134879.HKD","LU2168564495.EUR","BK4550","LU0070217475.USD","LU2087625088.SGD","SGXZ51526630.SGD","IE00B19Z8W00.USD","AMZP","ELMT","LU2750360641.GBP","LU1046421795.USD","IE00BKPKM429.USD","LU1261432733.SGD","LU1323610961.USD","IE0005OL40V9.USD","LU0251131958.USD","LU1066053197.SGD","LU1861558580.USD","LU0130103400.USD","BK4551","BK4579","LU0149725797.USD","LU2357305700.SGD","LU0348723411.USD","GB00BDT5M118.USD","LU2092627202.USD","LU2461242641.AUD","IE00B5949003.HKD","LU2746668974.SGD","IE0001KFT4U8.USD","LU1934455863.HKD","LU0342679015.USD","LU1366192091.USD","LU0417517546.SGD","LU1496350171.SGD","LU1861127337.USD","LU2456880835.USD","LU1244550221.USD","AMZY","USAW.SI","LU2265009873.SGD","LU1201861249.SGD","LU2023250843.SGD","IE00BKDWB100.SGD","LU0109392836.USD","IE000F7OJYX1.SGD","LU2168564065.EUR","LU0724617625.USD","LU0310799852.SGD","SG9999004303.SGD","LU0820561909.HKD","LU1868836591.USD","LU0788109477.HKD","SGXZ99366536.SGD","LU0943347566.SGD","LU1035775433.USD","IE00B7SZLL34.SGD","LU1974910355.USD","BK4554","LU2361044865.SGD","SGXZ31699556.SGD","LU0211327993.USD","IE00BJTD4V19.USD","LU0353189763.USD","LU1718418525.SGD","IE000KEQY171.SGD","BK4139","LU0234572021.USD","SG9999018857.SGD","BK4516","IE00BFSS8Q28.SGD","HK0000532082.HKD","LU1917777945.USD","LU2247934214.USD","LU2471134796.USD","BK4592","LU0965509101.SGD","LU0672654240.SGD","LU2360032135.SGD","BK4566","LU0949170426.SGD","LU0640476718.USD","LU0079474960.USD","LU0203201768.USD","LU1201861165.SGD","LU0345774391.USD","IE000M9KFDE8.USD","LU0077335932.USD","LU0011850046.USD","LU2602419157.SGD","LU0208291251.USD","BK4561","LU1935042215.USD","LU1064131342.USD","SG9999000418.SGD","LU2211817866.USD","LU2089284900.SGD","LU2764263039.SGD","ONLN","IE00B1XK9C88.USD","LU0072461881.USD","LU0345769631.USD","LU1791710582.SGD","LU0096364046.USD","LU0882574139.USD","LU1674673428.USD","IE00BJJMRY28.SGD","IE00B775SV38.USD","LU0985320562.USD","LU2362541273.HKD","LU0965508806.USD","LU1366333091.USD","LU0256863902.USD","LU1633808545.USD","IE00BK4W5L77.USD","AMZW","LU0323591593.USD","LU0784384876.USD","IE00BQXX3C00.GBP","BK4503","IE00BQXX3D17.EUR","LU2430703095.HKD","BNC","LU2023250330.USD","LU0128525929.USD","LU1301847155.USD","LU2237438978.USD","LU2764262908.HKD","LU1066051225.USD","LU1868837136.USD","HK0000304797.USD","LU0080751232.USD","LU0648000940.SGD","LU2097829019.USD","LU2471134523.USD","IE00BMPRXN33.USD","LU0157215616.USD","IE00B4JS1V06.HKD","IE0034235303.USD","IE00B7KXQ091.USD","IE0002270589.USD","LU0061474960.USD","LU0965509010.AUD","LU2750360997.AUD","IE00BWXC8680.SGD","LU1804176565.USD","LU0170899867.USD","LU0265550946.USD","LU1674673691.USD","SGXZ81514606.USD","LU2077746001.SGD","BK4598","LU1127390331.HKD","LU2125154778.USD","LU0072462426.USD","OGIG","LU0456855351.SGD","LU0289941410.SGD","IE000SO60NU8.SGD","BK4548","LU1814569148.SGD","LU0787776722.HKD","LU2083900584.USD","CLIX","IE00B3SWFQ91.USD","LU0784383803.USD","AMZU","LU0353189680.USD","IE00BYQQ9H92.USD","LU1235294995.USD","LU2403377893.USD","LU0742534661.SGD","LU2552382058.USD","LU1629891620.HKD","IE00B19Z8X17.USD","BK4538","LU2452424414.USD","BK4527","LU0210536198.USD","LU0158827781.USD","IE00BN29S564.USD","IE000ITXATA3.USD","LU1935043452.HKD","LU0162691827.USD","LU0210533765.USD","IE00BJLML261.HKD","LU0154236417.USD","LU1280957306.USD","LU2211815571.USD","LU0143551892.USD","AMZZ","SG9999015978.USD","LU0314104364.USD","LU2720916845.USD","LU0109391861.USD","LU2463028550.USD","LU0823421416.USD","LU1116320737.USD","LU2954938101.SGD","LU2087621335.USD","LU0238689110.USD","LU1267930490.SGD","LU2896262040.SGD","SG9999014906.USD","IE00B5TLWC47.USD","IE00B1BXHZ80.USD","LU1232071149.USD","LU1435385759.SGD","LU0320765489.SGD","HULL","LU0964807845.USD","LU1778281490.HKD","WANT","LU2505996509.AUD","IE00BFSS7M15.SGD","SAMZNmain","IE0004445015.USD","LU0345769128.USD","LU2168563687.JPY","LU0345768153.USD","LU2065171311.SGD","LU2326559502.SGD","LU0107464264.USD","LU0096362180.USD","BK4534","LU2106854487.HKD","HK0000304805.HKD","LU0251132253.USD","LU2242649171.HKD","LU1074936037.SGD","LU0234570918.USD","LU2764263203.CNY","HK0000914686.HKD","LU0302445910.USD","IE00BZ1G4Q59.USD","LU0823434740.USD","IE00BFXG0V08.USD","LU1803068979.SGD","LU1868836914.USD","LU0980610538.SGD","LU1551013425.SGD","LU0820561818.USD","IE000BZT7R73.USD","IE0003U64NQ7.SGD","SG9999015952.SGD","IBRN","LU1914381329.SGD","LU0308772762.SGD","LU1989764664.SGD","LU0354030511.USD","LU1861559042.SGD","IE00B775H168.HKD","LU0158827948.USD","BK4543","LU1815333072.USD","IE00BK4W5M84.HKD","LU0784385170.HKD","SGXZ80539844.SGD","AMZD","LU2361044949.HKD","LU0053666078.USD","LU0211328371.USD","LU1116320901.HKD","LU2028103732.USD","LU2592432038.USD","LU2552382215.SGD","AZYY","LU1316542783.SGD","LU0354030438.USD","BK4532","SG9999015986.USD","RUM","LU2250418816.HKD","IE000WAW04H5.SGD","LU0289960550.SGD","LU2430703251.USD","LU1496350502.SGD","AMZG","SG9999014880.SGD","BK4559","BK4507","LU2111349929.HKD","LU2168564149.EUR","LU1720051108.HKD","THNR","LU2236285917.USD","LU1548497426.USD","LU2362540622.SGD","BK4535","LU0316494557.USD","LU2264538146.SGD","LU1935042991.SGD","LU2023251221.USD","BK4533","LU0820562030.AUD","LU0683600562.USD","LU0965509283.SGD","LU1267930730.SGD","LU2361045086.USD","LU0708994859.HKD","LU1244550577.SGD","LU0345768740.USD","LU0251142724.SGD","LU0494093205.USD","IE00BJTD4N35.SGD","BK4588","LU0889565833.HKD","LU2054465674.USD","IE00BQXX3F31.USD","LU0784385840.USD","LU2417539215.USD","LU0133085943.USD","BK4585","LU1069344957.HKD","LU0048584097.USD","IE0004086264.USD","LU0310800379.SGD","LU1935043536.SGD","LU2362541513.USD","LU1267930573.SGD","SG9999002224.SGD","IE00B4YYXB79.USD","HK0000914660.USD","LU0312595415.SGD","LU2746668461.USD","LU2543165471.USD","SGXZ44715902.SGD","LU0265550359.USD","LU1868837300.USD","LU2275660780.HKD","LU0466842654.USD","IE0009G5SDU7.USD","LU2317271919.USD","LU1145028129.USD","IE00B19Z9505.USD","LU2430703178.SGD","IE00B3S45H60.SGD","LU0267386448.USD","ILDR","BK4077","LU2462591277.SGD","SG9999002232.USD","LU2552382132.HKD","LU2168564222.USD","LU2092937148.SGD","LU1839511570.USD","LU0029864427.USD","LU1935042488.USD","LU0719512351.SGD","IE00BJJMRX11.SGD","LU0127658192.USD","IE00B19Z3581.USD","LU1084165304.USD","LU0320765059.SGD","LU1934455194.USD","LU0823421333.USD","SG9999018865.SGD","IE0009356076.USD","BK4122","BK4596","LU0203202063.USD","LU2237957811.SGD","LU2637965513.SGD","BK4524","LU2471134952.CNY","LU0708995401.HKD","LU1988902786.USD","LU2756315664.SGD","LU0345770993.USD","IE000W1ABFV2.USD","LU0823434583.USD","LU0861579265.USD","BK4161","LU0256863811.USD","LU2108987350.USD","SG9999014898.SGD","LU1720051017.SGD","SG9999017495.SGD","LU0528227936.USD","LU2462591350.SGD","LU0345770308.USD","LU1791710400.SGD","LU1037948541.HKD","LU2860962120.EUR","LU0061475181.USD","LU2065169927.USD","RTH","LU2237957902.USD","SRRK","LU1119994496.HKD","LU2999663052.SGD","LU0276348264.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667570096","title":"Truist Raises Price Target on Scholar Rock Holding to $76 From $55, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667570096","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667570096?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:36","pubTimestamp":1789382207,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding (SRRK) has an average rating of buy and mean price target of $65.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRRK","BK4139","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657427","title":"Scholar Rock Shares up 11.6% Premarket After FDA Nod for First Muscle-Targeted Drug for Type of Genetic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657427?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:27","pubTimestamp":1789381630,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4560OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","IBRN","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657957","title":"Scholar Rock Holding Corporation : Citigroup Raises Target Price to $74 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657957?lang=en_us&edition=fundamental","pubTime":"2026-09-14 18:17","pubTimestamp":1789381038,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN45605Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","SRRK","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654477","title":"One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654477","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654477?lang=en_us&edition=fundamental","pubTime":"2026-09-14 17:30","pubTimestamp":1789378200,"startTime":"0","endTime":"0","summary":"Tiffinne Perkins, a nurse practitioner who ran an Ohio-based weight-loss clinic called Enbody, appeared on the local news and lifestyle morning show \"New Day Cleveland.\"\"How many people got skinny thanks to you lately?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","LU1804176565.USD","SG9999018865.SGD","LU0689472784.USD","CURE","LU1061106388.HKD","IHE","LU1989771016.USD","LU0094547139.USD","IE00BJJMRY28.SGD","LU0210536198.USD","AGNG","IE00BKDWB100.SGD","TRUH","XLV","LU2237443465.HKD","LU0079474960.USD","LU2237443382.USD","TMED","LU0471298777.SGD","LU2756315664.SGD","IYH","BK4534","SG9999001176.SGD","LU0114720955.EUR","RXL","LU1035775433.USD","LU0345770308.USD","LU0353189763.USD","HRTS","LU2089984988.USD","LU2461242641.AUD","SG9999015978.USD","LU1720051017.SGD","LU2756315318.SGD","LU0672654240.SGD","LU2265009873.SGD","LU2456880835.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU2213496289.HKD","LU2552382215.SGD","IE0004445015.USD","SG9999013999.USD","BK4581","FHLC","IE00BFSS8Q28.SGD","GB00BDT5M118.USD","LU0354030511.USD","LU0787776722.HKD","LU1093756168.USD","LU2211815571.USD","SG9999015952.SGD","IE00BJT1NW94.SGD","LU0238689110.USD","LU2087625088.SGD","LU2471134796.USD","THNR","IE00BJJMRZ35.SGD","LU2417539215.USD","IE00BK4W5M84.HKD","LU1979441026.SGD","SG9999018857.SGD","LU1093756325.SGD","LU0096364046.USD","LU0417517546.SGD","LU0466842654.USD","LU2237443622.USD","LU1868836591.USD","LU0256863902.USD","SG9999014906.USD","LU0456855351.SGD","LU2112291526.USD","LU0708995401.HKD","LU0823434740.USD","IE00BN29S564.USD","LU1323610961.USD","LU0320765059.SGD","LU1629891620.HKD","LU0256863811.USD","LU1917777945.USD","LU1291159041.SGD","LU1868836914.USD","LU0158827948.USD","LU1868837136.USD","LU0640476718.USD","VHT","OZEM","LU1232071149.USD","LU0266013472.USD","LU2023250330.USD","MHIP","SG9999015986.USD","WDNA","LU1974910355.USD","LU0882574139.USD","IE00BK4W5L77.USD","IE0004445239.USD","SG9999014898.SGD","BK4533","LU0354030438.USD","LU0225283273.USD","LU1064131342.USD","LU2360106947.USD","LU0106261372.USD","IE00BFSS7M15.SGD","IE00B775H168.HKD","JDOC","LU2264538146.SGD","LU0385154629.USD","LU2324357040.USD","LU1814569148.SGD","LU0289739699.SGD","LU2063271972.USD","LU2471134952.CNY","IE00B4R5TH58.HKD","SGXZ31699556.SGD","LU0964807845.USD","ELIL","LU2168563687.JPY","LU0320765992.SGD","LU2106854487.HKD","LU1691799644.USD","LU0345770993.USD","LU2168564495.EUR","PJP","LU2271345857.HKD","IE00B1BXHZ80.USD","SGXZ57979304.SGD","LU0158827781.USD","LLY","LU2361045086.USD","MEDI","CANC","BK4007","LU1280957306.USD","LU1868837300.USD","LU0058720904.USD","LU1983299246.USD","LU2028103732.USD","LU2168564149.EUR","SG9999014880.SGD","SGXZ81514606.USD","LU1127390331.HKD","LU0316494557.USD","LU0109391861.USD","LU1023059063.AUD","LU0109394709.USD","LU2471134523.USD","LU2746668974.SGD","LU0882574055.USD","LU0122379950.USD","SGXZ99366536.SGD","LU1069344957.HKD","LU2552382058.USD","LU2602419157.SGD","LU0820561909.HKD","LU2491050071.SGD","LU2468319806.SGD","LU1366192091.USD","LU0203202063.USD","IE00BKPKM429.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU1267930730.SGD","LU2023251221.USD","LU2237443549.SGD","IE00B7KXQ091.USD","LU0203201768.USD","LU2361044865.SGD","LU2750360997.AUD","LU2023250504.SGD","ILDR","IE0005OL40V9.USD","IE00B1XK9C88.USD","PPH","BK4516","LU2111349929.HKD","LLYX","LU0198837287.USD","LU2108987350.USD","LU1988902786.USD","LU2462591350.SGD","LLYZ","LU0323591593.USD","LU0823416689.USD","BK4588","LU2089284900.SGD","IE0002141913.USD","LU2236285917.USD","IE0001KFT4U8.USD","LU2462157665.USD","LU0006306889.USD","SG9999014914.USD","LU0943347566.SGD","LU0889565916.HKD","LU0061475181.USD","LU0786609619.USD","IE00BWXC8680.SGD","LU0174119429.USD","LU0820562030.AUD","LU1551013342.USD","LU0683600562.USD","GDOC","LU2168564222.USD","LU2357305700.SGD","LU0820561818.USD","LU2491049909.HKD","LU1145028129.USD","LU2896262040.SGD","LU1548497426.USD","MEDX","LU2089283258.USD","LU2746668461.USD","LU0133085943.USD","LU0353189680.USD","LU1057294990.SGD","LU2237443978.SGD","LU2168564065.EUR","LU1720051108.HKD","LU0097036916.USD","LU0471298694.HKD","LU1623119135.USD","LU2750360641.GBP","LU2361044949.HKD","BK4585","FTXH","LU2491050154.USD","LLII","LU2237443895.HKD","LU2471134879.HKD","LU2552382132.HKD","IE00B4JS1V06.HKD","LU0823434583.USD","IE00BFTCPJ56.SGD","BK4599","IE00BJLML261.HKD","LU0234572021.USD","SG9999015945.SGD","LU2237438978.USD","LU0432979614.USD","ELIS","SGXZ51526630.SGD","SG9999017495.SGD","SG9999001176.USD","IE0009355771.USD","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643659","title":"Scholar Rock Gets FDA Approval for Spinal Muscular Atrophy Treatment in Children, Adults; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643659","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643659?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374609,"startTime":"0","endTime":"0","summary":"Scholar Rock  has received US Food and Drug Administration approval for Isembyld to treat spinal muscular atrophy in certain patients aged two years and above, the company said Friday.Isembyld is expected to ship in the coming days, Scholar Rock said, adding that the company has received a rare pediatric disease priority review voucher that may be used to obtain priority review for a future marketing application.Spinal muscular atrophy is a severe neuromuscular disease that leads to an irreversible loss of motor neurons and progressive muscle wasting.Scholar Rock shares were up 8.6% in premarket activity Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","THNR","BK4585","IBRN","LABU","SRRK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667365962","title":"Novo Nordisk to Rebrand as Novo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667365962","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667365962?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:28","pubTimestamp":1789374480,"startTime":"0","endTime":"0","summary":"Wegovy maker Novo Nordisk said it is rebranding as Novo, as the Danish drugmaker prepares to give a strategy update later this month.The company said Monday that its new corporate identity with the single Novo name aims to make it more recognizable and consistent in the way it reaches people to compete in an increasingly consumer-driven market for obesity medications.\"'Novo' will be used as the name of the company day-to-day, while Novo Nordisk A/S remains the legal global company name,\" it said.The company said it would emphasize competitiveness in its corporate culture going forward. The rebrand and shift in culture are part of changes Novo plans to introduce to deliver on its business objectives, it added.Novo has scheduled an event with investors for Sept. 21, when it expects to provide an update on its new corporate strategy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","BK4599","THNR","IE00BKVL7J92.USD","OZEM","NVOX","BK4585","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","PPH","BK4588","NVOH","NVOC","NVO","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639042","title":"Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Scholar Rock Holding (SRRK) and Danaher (DHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639042?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:30","pubTimestamp":1789349409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Summit Therapeutics (SMMT), Scholar Rock Holding (SR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-scholar-rock-holding-srrk-and-danaher-dhr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-summit-therapeutics-smmt-scholar-rock-holding-srrk-and-danaher-dhr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","LU1923621640.USD","BK4585","LU0114720955.EUR","LU0511384066.AUD","LU2211814178.USD","BK4588","LU0097036916.USD","LU0187121727.USD","IE00BQXX3F31.USD","LU1267930730.SGD","LU0943347566.SGD","HCSG","SRRK","LU2125910336.SGD","XLV","BK4534","LU0029874061.USD","LU0289739343.SGD","THNR","LU1791710582.SGD","XBI","LU0820561818.USD","LU0312595415.SGD","LU0109391861.USD","LU2063271972.USD","LABU","IE000M9KFDE8.USD","LU0528227936.USD","LU2125909593.SGD","FMED","LU2265009873.SGD","LU1804176565.USD","DHR","LU2112291526.USD","SMMT","LU0289960550.SGD","IE00BQXX3D17.EUR","LU2125909247.SGD","BK4581","SGXZ57979304.SGD","LU1057294990.SGD","IE00BKVL7J92.USD","LU0708995401.HKD","LU2023250504.SGD","LU0320765059.SGD","LU1061106388.HKD","LU1974910355.USD","LU0820562030.AUD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666950493","title":"Novo Nordisk Stock Slides as GLP-1 Fears Mount","url":"https://stock-news.laohu8.com/highlight/detail?id=2666950493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666950493?lang=en_us&edition=fundamental","pubTime":"2026-09-12 22:01","pubTimestamp":1789221684,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has fallen by -7.58%. Read on to learn why. Novo Nordisk shares fell 7.58% over the past week as investor sentiment weakene...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/novo-nordisk-stock-slides-as-glp-1-fears-mount?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/novo-nordisk-stock-slides-as-glp-1-fears-mount?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","NVOC","BK4007","OZEM","BK4599","THNR","LU0154236417.USD","PPH","NVOX","NVO","IE00BKVL7J92.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","GB00BDT5M118.USD","LU2417539215.USD","LU0385154629.USD","LU0208291251.USD","LU0320765489.SGD","IE00BKVL7J92.USD","LU2456880835.USD","IE00BK4W5M84.HKD","LU2242652126.USD","IHE","IE00BKPKM429.USD","LU1974910355.USD","IE00B775H168.HKD","LU2168564222.USD","TBXU","LU1267930730.SGD","LU0786609619.USD","GDOC","SGXZ57979304.SGD","LU1917777945.USD","SG9999015978.USD","AGNG","LU0133085943.USD","LU0889565916.HKD","LU0174119429.USD","LU0964807845.USD","SGXZ99366536.SGD","IXJ","LU1280957306.USD","SG9999017495.SGD","LU0114720955.EUR","LU1868836914.USD","LU1551013425.SGD","LU0787776722.HKD","LU0122379950.USD","LU0689472784.USD","LU2750360641.GBP","LU1366192091.USD","LU1629891620.HKD","LU0820561909.HKD","LU1720051108.HKD","LU2361044949.HKD","LU2746668974.SGD","IE00B1BXHZ80.USD","ELIS","LU0432979614.USD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2023250504.SGD","LU2491050071.SGD","MHIP","LU2271345857.HKD","BBH","SG9999018865.SGD","LU0640476718.USD","BK4588","BK4533","LU0820561818.USD","LU1623119135.USD","NVOH","LU0106261372.USD","TRUH","SG9999001176.SGD","OZEM","SG9999014914.USD","FTXH","IE00BFSS8Q28.SGD","SG9999018857.SGD","LU0058720904.USD","LU0320765059.SGD","LU1989771016.USD","LU0097036916.USD","LU1868836591.USD","LU1868837300.USD","LU2168564149.EUR","SG9999013999.USD","LU0471298777.SGD","LU2361044865.SGD","LU0466842654.USD","LU2264538146.SGD","LU0868494617.USD","LU2168564495.EUR","LU2168563687.JPY","BK4516","LU0289739699.SGD","LU0109394709.USD","LU2213496289.HKD","IE00BK4W5L77.USD","LU2237438978.USD","LU0061475181.USD","NVS","SG9999014880.SGD","IE0002141913.USD","LU1232071149.USD","LU2023250330.USD","HRTS","LU2237443622.USD","LU2471134879.HKD","LU2491049909.HKD","LU2236285917.USD","LU0096364046.USD","LU0109391861.USD","LU0345770308.USD","LU2462157665.USD","LU2063271972.USD","LU2023251221.USD","LU0006306889.USD","LU0198837287.USD","CANC","LU2237443978.SGD","SG9999014898.SGD","BK4581","LU1571399168.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU0234572021.USD","LU0210536198.USD","IE0004445239.USD","LU0079474960.USD","LU0456855351.SGD","LU1093756168.USD","04332","AMGN","LU2471134796.USD","LU2750360997.AUD","LU2237443549.SGD","LU2552382215.SGD","IE0005OL40V9.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1035775433.USD","BK4532","IE00BJLML261.HKD","LU1023059063.AUD","LU2461242641.AUD","LU0471298694.HKD","LU2237443895.HKD","LLY","PJP","LU2211815571.USD","LU1548497426.USD","LU0323591593.USD","LU0158827948.USD","LU0211331839.USD","IE00BJJMRZ35.SGD","LU2756315664.SGD","LU0094547139.USD","LU0417517546.SGD","LU0823434583.USD","LU2896262040.SGD","XLV","LU2089284900.SGD","LU0823434740.USD","IE0009355771.USD","LU0320765992.SGD","LU1064131342.USD","THNR","FHLC","SGXZ81514606.USD","LU1983299246.USD","LU2242646821.SGD","LU0203202063.USD","IE0001KFT4U8.USD","LU0353189680.USD","LLYX","SG9999014906.USD","IE00BJJMRX11.SGD","LU2111349929.HKD","JDOC","IE00BZ1G4Q59.USD","LU2265009873.SGD","PPH","SGXZ31699556.SGD","BK4534","LU2112291526.USD","LU1127390331.HKD","NVOC","LU0353189763.USD","LU2089984988.USD","BIB","LU1988902786.USD","LU1814569148.SGD","ELIL","WDNA","LU1323610961.USD","LU0154236417.USD","LU0238689110.USD","LU1868836757.USD","IE00B7KXQ091.USD","TMED","NVOX","LU0266013472.USD","LU2106854487.HKD","LU0158827781.USD","LU2471134952.CNY","ILDR","BK4599","IBB","LU0354030438.USD","LU0203201768.USD","LU1712237335.SGD","LU2756315318.SGD","LU2087625088.SGD","MEDI","PBE","SG9999015952.SGD","IYH","LU0316494557.USD","LU0256863811.USD","LU1061106388.HKD","LU1145028129.USD","LU2324357040.USD","LU1720051017.SGD","LU1093756325.SGD","LU2471134523.USD","LU2357305700.SGD","CURE","BK4007","LU0820562030.AUD","IE00B4JS1V06.HKD","LU2237443465.HKD","LU0882574055.USD","LU2462591350.SGD","LU2491050154.USD","LU1804176565.USD","LU0683600562.USD","IE00BFSS7M15.SGD","LU0672654240.SGD","RXL","IE00BN29S564.USD","LU2361045086.USD","IE00BKDWB100.SGD","LU0225283273.USD","SG9999015986.USD","LU0708995401.HKD","BK4139","SG9999001440.SGD","BK4585","LLYZ","LU0345770993.USD","LU0070302665.USD","LU0354030511.USD","LU1057294990.SGD","LU1291159041.SGD","LU1551013342.USD","BK4566","LU1691799644.USD","LU2168564065.EUR","LU2468319806.SGD","LU2552382132.HKD","LU0882574139.USD","LU2108987350.USD","LU0943347566.SGD","IE00B2B36J28.USD","BK4578","LU2360106947.USD","LU2746668461.USD","LU2237443382.USD","LU0823416689.USD","LU1069344957.HKD","IBBQ","LU2552382058.USD","VHT","LU2089283258.USD","LU1979441026.SGD","LU2602419157.SGD","LLII","NVO","SGXZ51526630.SGD","IE0004445015.USD","MEDX","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU0256863902.USD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169242709","title":"ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1169242709","media":"ETF Weekly","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169242709?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:01","pubTimestamp":1789171282,"startTime":"0","endTime":"0","summary":"Market OverviewFor Sep 07 – Sep 11, 2026, the Dow Jones Industrial Average fell 1.57%, the S&P 500 slipped 0.80%, and the Nasdaq Composite eased 0.66%.ETF market breadth skewed defensive, with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b73ff2cc9bf460e9cf84e18c58740f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BWET","LU2456880835.USD","OUNZ","IE00BZ1G4Q59.USD","LU2265009873.SGD","LU0792757196.USD","AMDD","AAAU","FAI","USXF","IE00BMPRXR70.SGD","LU1861558580.USD","LU1880398471.USD","LU1303367103.USD","IETC","LU0174119429.USD","LU0274383776.USD","ASHR","HOOC","IE00BGHQF748.EUR","PSI","MSTK","MSTX","SMHX","IAUI","SGOL","WUGI","LU2896262040.SGD","DUST","LU2095319765.USD","QQQA","FLCH","FXP","HOOI","IE00B1BXHZ80.USD","DIA","LU0056508442.USD","HOOX","TTEQ","LEGR","BK4573","BK4554","PILL","SMST","SCO","IE0009356076.USD","SIVR","FLTR","BK4550","AGQ","BK4570","LU0979878070.USD","BK4539","MST","IMST","IE00BMPRXQ63.HKD","LU0048584097.USD","IE00BQXX3F31.USD","DRN","LU2461242641.AUD","XPP","LU2264538146.SGD","LU2360107168.USD","LU2361044949.HKD","BK4532","MSTW","NVOX","AMDL","PPH","GDXW","BK4112","BAR","LU2360106780.USD","IAU","LU0198837287.USD","BK4127","USG","LU2242649171.HKD","SOXY","UCO","SG9999014013.SGD","CWEB","TZA","82823","LU1093756325.SGD","AMDU","LU1861220033.SGD","IAUM","SGXZ51526630.SGD","KWEB","IE00BQXX3D17.EUR","LU2247934214.USD","BIL","SG9999001424.SGD","LU2361045086.USD","FAZ","LU0154236417.USD","BK4547","IE00BMPRXN33.USD","LU1232071149.USD","LU1804176565.USD","NVOH","USSX","DZZ","LU1861215975.USD","MSTZ","82843","IE00BN0W2T93.GBP","ILDR","SG9999014039.USD","BPAY","LU0082616367.USD","DOG","FLOT.AU","LU0081259029.USD","YXI","IAI","SGXZ99366536.SGD","LU1093756168.USD","LU2108987350.USD","FLOT","ZSL","FDN","LU1267930813.SGD","LU1064131342.USD","AMD","BK4566","LU2210149790.SGD","BK7104","IE00B64PRP62.GBP","LU0133085943.USD","LU1242518931.SGD","CNAV","SG9999014021.USD","SMH","FGDL","SLV","GDXY","WNTR","DAMD","BK4141","BK7084","BK4588","BLCK","CRPT","DRV","HOII","IE00BN0W2W23.USD","BK4612","LU2462591350.SGD","MSTU","ROBN","LU2054465674.USD","SOXX","URTY","LU1989772840.SGD","GLL","LU2236285917.USD","BK4007","LU0823434740.USD","CHAT","LU2361044865.SGD","HOOD","TEK","LU0390134368.USD","02823","LU0889566641.SGD","YINN","UWM","LU0823434583.USD","LU2458330243.SGD","LU0642271901.SGD","LU1803068979.SGD","LU2543165471.USD","LU1852331112.SGD","CHPS","LU2098885051.SGD","SDOW","BGLD","LU1880398554.USD","NUGT","LU1989772923.USD","IE00BKVL7J92.USD","07399","OZEM","LU0889565833.HKD","SHNY","LU0823421333.USD","AMUU","BK4575","FINX","USO","DDM","WISE","XNTK","HOOG","IWM","UDOW","LU1989764664.SGD","BK7142","MSTC","LU0127658192.USD","BK7095","LU2355687059.USD","DULL","82822","BK4614","KGLD","LU2458330169.SGD","MTYY","SOXL","LU2931357623.SGD","SGXZ81514606.USD","02843","GAMR","BK4512","BK4585","IE0001KFT4U8.USD","MSII","AIS","MSTR","MSTY","THNR","LU2860962120.EUR","SMN","BK4534","BK4543","IE00BQXX3C00.GBP","RWM","LU2290526834.HKD","LU0823421416.USD","MINT","HOOW","LU0251132253.USD","ARTY","BK7504","IE00B3QW5Z07.USD","LU0109392836.USD","IE00BKPKM429.USD","USFR","IGLD","SG9999014005.SGD","LU2210150020.SGD","VTWO","AMDY","MSDD","MSST","FTXL","SOXS","MSTP","AMDC","LU1316542783.SGD","02822","ASHS","DBC","BK4605","LU2417539215.USD","BK4599","LU0719512351.SGD","LU2250418816.HKD","NVO","AIQ","DXD","HODU","NVOC","TNA","AMDW","UGL","TWM","LU1988902786.USD","YANG","LU1861559042.SGD","AMYY","IE00BN0W2V16.EUR","LU2089985449.USD","DGZ","CHAU","DGP","LU1242518857.USD","LU0314104364.USD","LU1951200564.SGD","AMDS","BK4529","BK4582","AMDG","LU0210536198.USD","HOYY","LU1923623000.USD","LU1989764748.USD","BCDF","IE00B5949003.HKD","LU1951198990.SGD","TRFK","GLD","GLDY","BAI","HOOZ","IE0004445239.USD","LU0786609619.USD","07799","YGLD","HOOY","GLDM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","THNR","RSPH","IBB","MRNX","PSCH","IBRN","NVIB","SRRK","IYH","BK4588","SYNB","PINK","LABU","BMED","TECB","BK4585","FRTY","LFSC","MRNY","TBXU","XLVX","MEDI","GDOC","GNMX","IEIH","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666572057","title":"FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy Patients Aged 2 and Older on SMN2 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666572057","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666572057?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165519,"startTime":"0","endTime":"0","summary":"FDA approves Scholar Rock’s ISEMBYLD for spinal muscular atrophy patients aged 2 and older on SMN2 therapyFDA cleared Scholar Rock’s ISEMBYLD (apitegromab-mstn) for spinal muscular atrophy in adults, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL2vCy1g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4139","SRRK","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666957270","title":"Scholar Rock Holding Corporation - Isembyld U.S. Commercial Launch Underway; Product Available to Ship in Coming Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2666957270","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666957270?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nTUA1TJGD4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","SRRK","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666706572","title":"Scholar Rock Announces FDA Approval of Isembyld™ (Apitegromab-Mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (Sma)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666706572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666706572?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nTUA1TJGD4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","THNR","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666572586","title":"US FDA Approves Scholar Rock's Muscle Weakness Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666572586","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666572586?lang=en_us&edition=fundamental","pubTime":"2026-09-12 05:24","pubTimestamp":1789161898,"startTime":"0","endTime":"0","summary":"US FDA approves Scholar Rock's muscle weakness drugSept 11 (Reuters)-The U.S. Food and Drug Administration on Friday approved Scholar Rock'sSRRK.Otherapy to treat a rare genetic condition that causes muscle weakness.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4N4531I3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0889565916.HKD","BK4588","LU0320765992.SGD","SRRK","IBRN","BK4532","IE00B894F039.SGD","LU0234570918.USD","BIIB","BMED","LU0109394709.USD","THNR","PBE","BK4585","BK4139","IE00B19Z9P08.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666357232","title":"US FDA - Approves Isembyld for Spinal Muscular Atrophy in Patients Aged 2 Years and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2666357232","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666357232?lang=en_us&edition=fundamental","pubTime":"2026-09-12 05:22","pubTimestamp":1789161732,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nFWN4530QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THNR","BK4139","SRRK","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}